Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Products>This Product
  Products


SpikeTidesTM peptides – light – heavy – quantified. The most economic source for quantified heavy peptides!

Product Image
Product Description

JPT’s SpikeTidesTM are customized, small scale, proteotypic peptides. They are produced light or isotopically labeled and /or absolutely quantified. Libraries of thousands of peptides at economic pricing become available for the first time due to JPT’s proprietary synthesis and quantification technology.

Applications for SpikeTidesTMDSC_8236_klein.gif
- Identification & optimization of proteotypic peptides
- Development of SRM/MRM assays
- Absolute and relative quantification of protein expression levels
- Biomarker discovery and validation
- Clinical monitoring of therapeutic invention and disease status

Benefits of SpikeTidesTM
- Most economic source for proteotypic peptides
- Compatible with current proteomic workflows
- Unmatched turnaround times (10 000 peptides within 2 weeks!)
- Delivery in ready-to-use microtiter plates
- JPT’s quantification method is as robust and much more cost effective than AAA

Specifications of your SpikeTidesTM

SpikeTidesTM
Small scale, unpurified proteotypic peptides
SpikeTidesTM_L
SpikeTidesTM with heavily labeled C-terminal lysine or arginine (Arg M +10 or Lys M +8)
SpikeTidesTM_TQ
SpikeTidesTM absolutely quantified using our patented Quanti-tag.
SpikeTidesTM_TQL
SpikeTidesTM with heavily labeled C-terminal lysine or arginine (Arg M +10 or Lys M + 8) and absolutely quantified using our patented Quanti-tag.


SpikeTidesTM  with Post-Translational Modifications
- Alkylation of cysteines (corresponding to iodoactamide method)
- Phosphorylation, glycosylation, methylation and other upon request

QC/QA for all SpikeTidesTM
ISO 9001:2008 Certification & GCLP Compliance

Selected References

•    Glatter et al.: "Large-Scale Quantitative Assessment of Different In-Solution Protein Digestion Protocols Reveals Superior Cleavage Efficiency of Tandem Lys-C/Trypsin Proteolysis over Trypsin Digestion" Journal of Proteome Research (2012)
•    Sabido et al.: "Targeted Proteomics of the Eicosanoid Biosynthetic Pathway Completes an Integrated Genomics-Proteomics-Metabolomics Picture of Cellular Metabolism" Mol Cell Proteomics (2012)
•    Hewel et al.: “Synthetic peptide arrays for pathway-level protein monitoring by LC-MS/MS.” Mol Cell Proteomics (2010)
•    Picotti et al.: "Full Dynamic Range Proteome. Analysis of S. cerevisiae by Targeted Proteomics" Cell (2009)

DSC_8305_klein.gif

Testimonials
"My unit at the Banting and Best Department of Medical Research, University of Toronto Centre for Cellular and Biomolecular Research (CCBR) works on the systematic identification and quantification of proteins and protein complexes on a global level. In addition we have started to perform targeted proteomics to study protein regulation within pathways, e.g. signaling pathways during stem cell fate decision. For this we used JPT's various SpikeTides™ peptide products to build LC-MRM assays in a fast and cost efficient manner. More recently we also found new ways of using low cost SpikeTides™ as quantitative peptide standards in order to quantify protein targets more accurately. We are currently in the process of validating this technology for the accurate quantification of various predicted microRNA targets."
Prof. Andrew Emili (Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Canada)

“We at the ETH successfully apply JPT’s unpurified isotope- and non-labeled peptide libraries for proteome-wide SRM assays allowing us to identify and quantify proteins spanning a broad range of abundances, including proteins not previously detectable. With the ability to produce large numbers of affordable small scale proteotypic peptides we envision for the first time the development of assays for the quantitative analysis for any protein of interest and covering of whole proteomes.”
Paola Picotti, PhD (Institute of Molecular Systems Biology, ETH Zürich, Switzerland)

Product SpikeTidesTM peptides – light – heavy – quantified. The most economic source for quantified heavy peptides!
Company JPT Peptide Technologies
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

JPT Peptide Technologies
Volmerstrasse 5, 12489 Berlin, Germany

Tel: +49-30-6392-7878 or 1.888.578.2660 (for USA/Canada)
Fax: +49-30-6392-7888 or 1.888.578.2666 (for USA/Canada)
Email: peptide@jpt.com



Scientific News
Platelets are the Pathfinders for Leukocyte Extravasation During Inflammation
Findings from the study could help in the prevention and treatment of inflammatory pathologies.
ASMS 2016: Targeting Mass Spectrometry Tools for the Masses
The expanding application range of MS in life sciences, food, energy, and health sciences research was highlighted at this year's ASMS meeting in San Antonio, Texas.
Benchtop Automation Trends
Gain a better understanding of current interest in and future deployment of benchtop automated systems.
Manufactured Stem Cells to Advance Clinical Research
Clinical-grade cell line will enable development of new therapies and accelerate early-stage clinical research.
Dengue Virus Exposure May Amplify Zika Infection
Researchers at Imperial College London have found that the previous exposure to the dengue virus may increase the potency of Zika infection.
Gender Determination in Forensic Investigations
This study investigated the effectiveness of lip print analysis as a tool in gender determination.
Identifying Novel Types of Forensic Markers in Degraded DNA
Scientists have tried to verify the nucleosome protection hypothesis by discovering STRs within nucleosome core regions, using whole genome sequencing.
Proteins in Blood of Heart Disease Patients May Predict Adverse Events
Nine-protein test shown superior to conventional assessments of risk.
Higher Frequency of Huntington's Disease Mutations Discovered
University of Aberdeen study shows that the gene change that causes Huntington's disease is much more common than previously thought.
Starving Stem Cells May Enable Scientists To Build Better Blood Vessels
Researchers from the University of Illinois at Chicago College of Medicine have uncovered how changes in metabolism of human embryonic stem cells help coax them to mature into specific cell types — and may improve their function in engineered organs or tissues.
Scroll Up
Scroll Down

Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,600+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!